said its surprise decision Thursday to withdraw the arthritis drug Vioxx -- used by about 2 million people worldwide -- was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits
Less than a week after Merck  Co
Company spokeswoman Maryann Caprino described FitzGerald's article as "an interesting hypothesis" but said that "in terms of the real world, we totally disagree
"I'm trying to prompt guidance from an unbiased source, and it should come urgently
The second article in the medical journal, by Dr
"But there are other things they can learn that are nonpharmacological
